As Freenome’s Chief Financial Officer, Linh drives the company’s financial strategy and operational execution as it prepares to scale its commercial footprint.

Linh brings over 20 years of experience in finance and operations across the diagnostics and Medtech sectors. Most recently, he served as CFO of Predicine, where he implemented a world-class revenue cycle management system and led market expansion across the U.S. Prior to that, he was chief operating officer at Ambry Genetics, where he led organizational transformation efforts that reduced test turnaround time by 30%. Linh also spent 14 years at Medtronic Diabetes, serving as CFO of its intensive insulin management business unit with oversight across North America, EMEA and Asia-Pacific.

He began his career in assurance at KPMG and PwC, followed by leadership roles at The Walt Disney Company and Fox. As a certified public accountant, Linh holds a Bachelor of Science in Business Administration and Accounting from California State University, Northridge, and has completed executive coursework at the Wharton School of Business. He was recognized as CFO of the Year by the Los Angeles Times in 2022.